CVE-2022-38801
MEDIUMCVSS 5.4/10EPSS 0.34%
Last modified
CVE-2022-38801 is a medium-severity vulnerability rated 5.4/10 on the CVSS scale. In Zkteco BioTime < 8.5.3 Build:20200816.447, an employee can hijack an administrator session and cookies using blind cross-site scripting.. EPSS estimates a 0.34% chance of exploitation in the next 30 days.
Description
In Zkteco BioTime < 8.5.3 Build:20200816.447, an employee can hijack an administrator session and cookies using blind cross-site scripting.
Metrics
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Zkteco | Biotime | < 8.5.4 |
References
- https://gist.github.com/hamoshwani/5ac860dd6757440174f446c62b24653fThird Party Advisory
- https://www.zkteco.com/Product
- https://gist.github.com/hamoshwani/5ac860dd6757440174f446c62b24653fThird Party Advisory
- https://www.zkteco.com/Product
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2022-38801?
In Zkteco BioTime < 8.5.3 Build:20200816.447, an employee can hijack an administrator session and cookies using blind cross-site scripting.
How severe is CVE-2022-38801?
CVE-2022-38801 has a CVSS score of 5.4/10 (MEDIUM severity). The EPSS model estimates a 0.34% probability of exploitation in the next 30 days.
How do I fix CVE-2022-38801?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2022-38801?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST